INR inowanzo shandiswa kuyera mhedzisiro yemishonga inorwisa ropa mumuromo muchirwere che thromboembolic. INR yakareba inoonekwa mumishonga inorwisa ropa mumuromo, DIC, kushomeka kwevhitamini K, hyperfibrinolysis nezvimwewo. INR yakapfupikiswa inowanzoonekwa mu hypercoagulable states uye thrombotic disorders. INR, inozivikanwawo seInternational Normalized Ratio, ndeimwe yezvinhu zvinoyedza coagulation function. INR yakavakirwa paPT reagent yekugadzirisa International Sensitivity Index uye kuverenga mhedzisiro kuburikidza nemafomula ane hukama. Kana INR yakakwira zvakanyanya, pane njodzi yekubuda ropa kusingadzoreki. INR inogona kunyatso tarisa uye kushandisa mhedzisiro yemishonga inorwisa ropa mumuromo. Kazhinji, mushonga unorwisa ropa mumuromo we warfarin unoshandiswa, uye INR inofanira kutariswa nguva dzese. Unofanira kuziva kuti kana warfarin ikashandiswa, INR inofanira kutariswa nguva dzose. Varwere vane venous thrombosis vanofanira kutora warfarin nemuromo, uye kukosha kweINR kunofanirwa kuchengetwa pa2.0-2.5. Kune varwere vane atrial fibrillation, inr value yewarfarin yemuromo inowanzo chengetwa pakati pe2.0-3.0. INR values iri pamusoro pe4.0 inogona kukonzera kubuda ropa kusingadzoreki, nepo INR values iri pasi pe2.0 isingape mushonga unoshanda wekudzivirira ropa kubva muropa.
Zano: uchiri kuenda kuchipatara chenguva dzose kunoongororwa, uye teerera zvakarongwa nachiremba ane hunyanzvi.
Beijing Succeeder inonyanya kugadzira zvigadzirwa zvekuongorora thrombosis uye hemostasis pamusika wepasi rose.
Seimwe yemakambani anotungamira muChina Diagnostic market yeThrombosis neHemostasis. SUCCEEDER ine ruzivo muzvikwata zveR&D, Production, Marketing Sales and Service, inopa coagulation analyzers uye reagents, blood rheology analyzers ESR neHCT analyzers, platelet aggregation analyzers, ISO13485 CE Certification uye FDA yakanyorwa.
Kadhi rebhizinesi
WeChat yeChinese